Status:
UNKNOWN
Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
Lead Sponsor:
Federico II University
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18-80 years
Brief Summary
Evaluation of adherence, persistence and efficacy of treatment with PCSK9 inhibitors in a real-life Italian population.
Eligibility Criteria
Inclusion
- Patients under PCSK9 inhibitor treatment.
Exclusion
- Age \< 18 years o \> 80 years;
- Patients who refuse to participate and to sign informed consent.
Key Trial Info
Start Date :
March 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05430828
Start Date
March 7 2020
End Date
March 31 2024
Last Update
September 28 2023
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedali dell'Ovest Vicentino
Arzignano, Italy, 36071
2
University of Bari Aldo Moro
Bari, Italy, 70121
3
University of Campania Luigi Vanvitelli
Caserta, Italy, 81100
4
University Magna Graecia of Catanzaro
Catanzaro, Italy, 88100